Search the Newsreel

What's Backing Abbott's Established Pharmaceuticals Division Growth

Abbott Laboratories' ABT Established Pharmaceuticals Division ("EPD") continues to be a solid growth contributor, supported by its broad portfolio of branded generic medicines and strong commercial presence across emerging markets. In the second quarter of 2026, EPD sales increased 8.4% on a reported basis …

Wolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffle

Investing.com -- Wolfe Research made two rating changes across large-cap medical devices, downgrading Stryker while upgrading Abbott Laboratories on Thursday. Analyst Mike Polark cut Stryker to Peer Perform, citing a demanding second-half setup following the company's March cyber disruption. He said the June quarter …

Here Are Thursday’s Top Wall Street Analyst Research Calls: Abbott Labs, AbbVie, Akamai Technologies, Five Below, Keurig Dr. Pepper, Salesforce, Stryker, StubHub, and More

This article details Wall Street analyst upgrades, downgrades, and initiations for various companies on Thursday, August 13, 2026, following the release of inline CPI data. Key movements include Five Below being upgraded to Buy at Jefferies and StubHub being cut to Underperform at Bank …

Die Abbott-Laboratories-Aktie legt nach starken Quartalszahlen und solider Guidance zu

Wolfe Upgrades AbbVie to Outperform From Peer Perform, Price Target is $300

Wolfe has upgraded AbbVie (ABBV) to an "Outperform" rating from "Peer Perform," setting a new price target of $300. This upgrade indicates a more positive outlook on the pharmaceutical company's stock performance. The article also lists recent news and analyst actions related to AbbVie, …

Year-round Royal Caribbean sailings from Singapore to begin in October 2026

Royal Caribbean International will begin year-round sailings from Singapore starting October 2026, featuring the Navigator of the Seas. This initiative, facilitated by TIRUN Travel Marketing, aims to offer Indian travelers more diverse and flexible cruise options across Southeast Asia, including itineraries to Vietnam, Malaysia, …

Cytokinetics sues Bristol-Myers in patent case (CYTK:NASDAQ)

Cytokinetics has filed a lawsuit against Bristol-Myers Squibb and its acquisition MyoKardia. The suit aims to prevent a potential patent infringement case concerning Cytokinetics' heart disease treatment, Myqorzo (aficamten). The dispute involves U.S. Patent No. 12,616,697.

AbbVie Inc. $ABBV Shares Acquired by Mission Wealth Management LP

Mission Wealth Management LP significantly increased its stake in AbbVie Inc. (NYSE:ABBV) by 119.1% in the second quarter, now holding 69,052 shares valued at $17.4 million. This move is part of a broader trend of institutional investors and hedge funds holding 70.23% of AbbVie's …

V. M. Manning & CO. Inc. Acquires New Position in Abbott Laboratories $ABT

V. M. Manning & CO. Inc. has acquired a new stake in Abbott Laboratories, purchasing 19,849 shares valued at approximately $1.8 million, making it their 11th largest holding. This move comes as Abbott Laboratories exceeded its quarterly earnings expectations and maintains a positive outlook …

McCollum Christoferson Group LLC Sells 62,644 Shares of Abbott Laboratories $ABT

Abbott India Q1 FY27 Results: Revenue Rs 1,813 Cr, PAT Rs 428 Cr and Key Highlights

Goodyear to fly 2 blimps over metro Detroit this weekend. Here's why

Goodyear will fly two blimps over metro Detroit this weekend for the first time in nearly 20 years to celebrate the Woodward Dream Cruise and the opening of a new Goodyear store. The blimps are Zeppelin NT semi-rigid airships capable of 80 mph and …

Handelsbanken Fonder AB Has $20.29 Million Stock Position in Hubbell Inc $HUBB

Handelsbanken Fonder AB reduced its stake in Hubbell Inc (NYSE:HUBB) by 7.7% in the second quarter, now holding 38,777 shares valued at $20.29 million. Other institutional investors have also adjusted their positions in Hubbell, which currently has a "Moderate Buy" consensus rating from analysts …

Abbott India Shares Fall 2.03% to Rs 27,570; Among Top Losers on Nifty Midcap 150

Abbott Laboratories $ABT Shares Acquired by DAVENPORT & Co LLC

Are Wall Street Analysts Predicting Royal Caribbean Cruises Stock Will Climb or Sink?

Royal Caribbean Group logo on ship by- sanafel via iStock With a market cap of $82.1 billion, Royal Caribbean Cruises Ltd. (RCL) is a global cruise vacation company and one of the largest players in the industry. The Miami, Florida-based company operates three wholly …

Die Bristol-Myers-Squibb-Aktie steigt nach Konsensstärke und solider Dividendenrendite

RBB Bancorp (RBB) Earnings Forecast: Future EPS & Revenue Growth Estimates

How the Parkinson’s Disease Community and AbbVie Are Shaping the Future of Care

AbbVie is collaborating with the Parkinson's disease community, including patients, researchers, and advocates, to advance research and improve care for the millions affected globally. With 20 years of research, AbbVie is focused on understanding disease progression, developing biomarkers, and enabling early diagnosis, while advocates …

Rep. Mike Kelly Unloads Abbott Laboratories (NYSE:ABT) Shares

Representative Mike Kelly sold shares of Abbott Laboratories (NYSE:ABT) valued between $1,001 and $15,000 on July 17th, as well as shares of PepsiCo and Walt Disney on the same day. This sale occurred despite Abbott Laboratories reporting a quarterly earnings beat and reaffirming its …

Bristol Myers Squibb (BMY) Invierte En Houston Y Reabre El Debate Sobre Su Valoración

ETFs Investing in RBB Bancorp Stocks

This article lists various ETFs that include RBB Bancorp stocks in their holdings. The ETFs are sorted by market value and include details such as weight, issuer, management style, focus, expense ratio, AUM, price, and NAV total return. This information aims to help investors …

Mike Kelly makes multiple trades including Abbott Laboratories and Disney stocks

Congressman Mike Kelly recently executed several trades through the Victoria Kelly Trust ICA, including selling stocks from Abbott Laboratories and The Walt Disney Company, each valued between $1,001 and $15,000. He also sold Pepsico, Inc. stocks worth $15,001 to $50,000. Additionally, Kelly purchased government …

BBB Foods (TBBB) Reports Q2 Earnings: What Key Metrics Have to Say

For the quarter ended June 2026, BBB Foods (TBBB) reported revenue of $1.5 billion, up 55.5% over the same period last year. EPS came in at -$0.19, compared to -$0.13 in the year-ago quarter. The reported revenue represents a surprise of +5.46% over the …

BBB Foods Chairman and CEO Converts 16 Million Class C Shares to Class A Shares

Kamal Anthony Hatoum, Chairman and CEO of BBB Foods Inc. (NYSE: TBBB), converted over 16 million Class C Common Shares to Class A Common Shares on August 7, 2026. This automatic conversion also applies to all associated vested and unvested RSUs, which will now …

BBB Foods (TBBB) Reports Q2 Loss, Beats Revenue Estimates

BBB Foods (TBBB) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to a loss of $0.13 per share a year ago. These figures are adjusted for non-recurring items. This quarterly …

Abbott Laboratories (ABT) Ties Lingo Glucose Data To AI Health Tools

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Abbott Laboratories (NYSE:ABT) and Google Health announced a multi year partnership to integrate Abbott's Lingo biowearable glucose data with Google's AI driven consumer health …

BBB Foods (TBBB): Capital Research Global Investors reports 7% ownership stake

Capital Research Global Investors has filed an amended Schedule 13G, disclosing a 7.0% beneficial ownership stake in BBB Foods Inc., amounting to 5,422,899 shares. The firm holds sole voting and dispositive power over these shares, which represent 7.0% of the 77,938,244 BBB Foods shares …

BBB Foods (NYSE:TBBB) Announces Quarterly Earnings Results, Misses Estimates By $0.03 EPS

How ABBV Stock Moved Away From Its Peer Group

AbbVie (ABBV) has shown strong fundamental performance with high revenue growth and operating margins, yet its stock returns significantly lag behind peers like Merck and Johnson & Johnson. This disconnect is attributed to the market pricing in future competitive threats to AbbVie's key drug …

BBB Foods (NYSE: TBBB) grows 2Q26 revenue 38.7% while remaining loss-making

BBB Foods Inc. (NYSE: TBBB) reported robust revenue growth in 2Q26, with total revenue increasing 38.7% year-over-year to Ps. 26,037 million, primarily driven by strong same-store sales and new store openings. Despite operational strength and a 43.8% rise in EBITDA (excluding share-based payments), the …

ABBOTT LABORATORIES AKTIE: AI-Analysen, Prognose & Kursziel

Tiendas 3B 2Q26 Earnings Release

MEXICO CITY, August 12, 2026--(BUSINESS WIRE)--BBB Foods Inc. ("Tiendas 3B" or the "Company")(NYSE: TBBB), a leading grocery hard discounter in Mexico, announced today its consolidated results for the second quarter of 2026 ("2Q26") ended June 30, 2026. The figures presented in this release are …

Enterprise value to revenue forward of Inch Kenneth Kajang Rubber Plc – MYX:INCKEN

The Abbott Big Ten $1 Million Blood Drive is Back

The Abbott Big Ten $1 Million Blood Drive returns for its third year, with Nebraska aiming to reclaim the title from Wisconsin. The competition, which runs from August 26th to December 4th, encourages donations to help address a national blood crisis, with a $1 …

Why Bristol Myers Squibb (BMY) Is Back In The Spotlight